Canandaigua National Corp Novartis Ag Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Novartis Ag stock. As of the latest transaction made, Canandaigua National Corp holds 5,899 shares of NVS stock, worth $584,590. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,899

Previous 5,698 3.53%

Holding current value

$584,590

Previous $433,000 23.56%

% of portfolio

0.09%

Previous 0.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $15,185 - $18,596	201 Added 3.53%	5,899 $535,000
Q3 2022 Oct 05, 2022	SELL	$74.61 - $87.26 $6,640 - $7,766	-89 Reduced 1.54%	5,698 $433,000
Q2 2022 Jul 05, 2022	SELL	$80.52 - $93.75 $37,924 - $44,156	-471 Reduced 7.53%	5,787 $489,000
Q1 2022 May 09, 2022	SELL	$80.11 - $90.62 $5,287 - $5,980	-66 Reduced 1.04%	6,258 $549,000
Q4 2021 Jan 04, 2022	BUY	$79.7 - $88.13 $28,213 - $31,198	354 Added 5.93%	6,324 $553,000
Q3 2021 Oct 04, 2021	SELL	$81.78 - $95.14 $1,063 - $1,236	-13 Reduced 0.22%	5,970 $488,000
Q2 2021 Jul 06, 2021	SELL	$85.24 - $94.15 $11,677 - $12,898	-137 Reduced 2.24%	5,983 $546,000
Q1 2021 Apr 05, 2021	SELL	$83.5 - $98.47 $49,265 - $58,097	-590 Reduced 8.79%	6,120 $523,000
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $8,119 - $9,820	-104 Reduced 1.53%	6,710 $634,000
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $6,981 - $7,735	-85 Reduced 1.23%	6,814 $593,000
Q2 2020 Jul 07, 2020	BUY	$80.93 - $91.1 $558,336 - $628,498	6,899 New	6,899 $603,000

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Novartis Ag Transaction History